Exabis Library
Welcome to the e-CCO Library!
P196: Major variance in scoring of endoscopic recurrence after ileocolic resection for Crohns Disease – a systematic review and meta-analysis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P196: Patients with ulcerative colitis (UC) and concomitant primary sclerosing cholangitis (PSC) have more subclinical endoscopic and histologic disease activity in the right colon compared to UC patients without PSC
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P196: Pre-treatment antibodies to infliximab and adalimumab are common but are not associated with anti-TNF treatment failure
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P196: Risk of venous thromboembolism according to disease activity, hospitalisation, or surgry in inflammatory bowel disease: a nationwide cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P196: Serum biomarkers reflecting tissue-remodelling correlates with the simple endoscopic score for Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P196: Visceral adiposity, genetic susceptibility, and risk of complications amongst individuals with Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P197 A snap-shot survey of IBD patients’ at a tertiary centre: a focus on knowledge and willingness to self-manage
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P197: A biomarker of early mucosal destruction: Neutrophil-mediated type IV collagen degradation is elevated in patients with Crohn's Disease and Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P197: Anogenital Crohn’s disease and granulomatosis: A systematic review of epidemiology, clinical manifestations, and treatment
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P197: Crohn’s disease recurrences after surgery: is there something new?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P197: Improved maternal and neonatal outcomes in a clinic dedicated to pregnant patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P197: Incidence and management of immunotherapy-induced colitis in a tertiary melanoma and IBD centre: Clinical practice data
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P197: The effect of a positive family history on the phenotype and course of paediatric Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P197: Use of 6-thioguanine nucleotide concentration test in the management of patients with Crohn’s disease in Korea
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P198 Colorectal cancer diagnosis in patients with inflammatory bowel disease in Spain: A room for improvement
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P198: An inflammatory serum metabolomic signature predicts response to vedolizumab treatment in people with Crohn’s Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P198: Are lower levels of faecal calprotectin reassuring in Crohn´s Disease patients?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P198: Dipeptidyl peptidase 4: a strong predictive marker of disease activity and treatment escalation in inflammatory bowel diseases
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P198: Faecal calprotectin level correlates well with balloon-assisted endoscopy and computed tomography enterography findings in small bowel Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P198: Multi-alleles predict primary non-response to infliximab therapies in Crohn’s disease: a simple and practicable model
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM